Erdosteine Market To Grow At 8% CAGR Till 2025

1
Global Erdosteine Market to hit 150 Mn by 2025
Global Market Insights Inc.
2
Industry Overview

• Erdosteine Market driven by Increasing
  pharmaceutical demand in the world to surpass USD
  150 million by 2025 and will witness 8 CAGR
  during the forecast timespan. Increasing demand
  for mucus regulating medicines owing to rise in
  air contaminants such as toxic gases, pollen,
  dust, organic material, emissions from vehicles
  and factories will boost the market for active
  pharmaceutical ingredient erdosteine.
  Contaminates in air cause inflammation of the
  larynx pharynx thus heightening the production
  of phlegm. The erdosteine based medicines market
  share will increase as they are used to reduce
  the viscosity and sticky nature of mucus, making
  it easier to cough.
• Change in consumer perceptions towards safety of
  medicines with factors such as clinical efficacy
  and low side effects will stimulate erdosteine
  market growth. It exhibits low side effects and
  has been given the designation of orphan drug by
  FDA.

3
Continue

• Erdosteine market demand from nasopharyngitis
  application may witness significant gains at
  around 5.5 by 2025. Increasing nasopharyngitis
  or common cold cases due to the rising allergy
  and weak immune system will boost the market for
  erdosteine based syrups and tablets. It is widely
  used in the pharmaceutical sector to reduce
  inflammation in the nasal passage.
• Excessive smoking habits increases respiratory
  diseases risk such as asthma bronchitis which
  exhibit the symptoms of cough, sore throat,
  stuffy nose, and congestion.
• U.S. erdosteine active pharmaceutical ingredient
  (API) market demand from contract manufacturing
  companies (CMOs) may witness significant gains at
  over 6.5 during the forecast period. Rise in
  consumer consciousness toward customized
  medicines and stringent government regulations on
  pharmaceutical products will stimulate market
  growth. Changing perceptions toward reduced costs
  and flexibility in manufacturing will boost the
  market share.

4

Browse Full Market Research Report Of Erdosteine
Market _at_ https//bit.ly/2ZzJ3Qi Request for
a Sample of this Research report _at_
https//www.gminsights.com/request-sample/detail/3
371
5
U.S. Erdosteine Market Size, By Application, 2018
2025, (Tons)

6
Industry Coverage

7
Continue

• Italy erdosteine market demand may expect
  consumption at over 35 tons during the predicted
  timeframe. Increase in elderly population and
  change in environmental conditions will boost the
  market for erdosteine based cough syrups and cold
  medicines. . Increased prevalence of respiratory
  problems such as nasopharyngitis owing to cold
  temperature and weakened immune systems will
  stimulate regional market growth. Moreover,
  increasing importance owing to medical research
  and technological innovation in this sector may
  contribute towards the regional industry growth.
• China erdosteine market demand may register
  significant gains at over 7 by the end of
  forecast period. Increasing cases of respiratory
  problems such as laryngopharyngitis and chronic
  sinusitis owing to rise in pollutions
  contaminants like pollen, oxides, and harmful
  gasses will boost the industry demand. Rising
  cases of bronchitis in India, China, and South
  Korea due to an increase in air contaminants such
  as carbon mono oxide will stimulate the market
  share.
• Taj Pharmaceuticals, Delta Finochem, Recipharm
  AB, Alitair Pharmaceuticals, Hanmi
  Pharmaceuticals, and Hikma Pharmaceuticals are
  key market players operating in erdosteine
  market.

8
Stay In Touch Website www.gminsights.com Soci
al Media